Kang...

China Concludes First-Ever Securities Class Action With a Slap-on-the-Wrist Order – Law.com

Kangmei Pharmaceuticals, one of China’s largest Chinese medicine makers, has been ordered to pay its 50,000 investors $385 million as compensation for their losses on their company’s stock. The matter marked closure to the country’s first-ever…

 

Read the full article here


-- END RSP MOD -->